Información:
Error:
ID
34587
Descripción
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled; ODM derived from: https://clinicaltrials.gov/show/NCT01699932
Link
https://clinicaltrials.gov/show/NCT01699932
Palabras clave
Versiones (1)
- 19/1/19 19/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
19 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Type 2 Diabetes Mellitus NCT01699932
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
patients with type 2 diabetes mellitus inadequately controlled despite a treatment with sulfonylurea (su) alone or metformin alone or a free combination of su and metformin prior to the study entry.
boolean
ID.2
Item
signed informed consent, obtained prior any study procedure
boolean
ID.3
Item
age < legal age of adulthood
boolean
ID.4
Item
hba1c < 7% or ≥ 11%
boolean
ID.5
Item
bmi > 35 kg/m2
boolean
ID.6
Item
treatment with a stable dose of maximally tolerated su alone or metformin alone or the free combination of su and metformin for less than 12 weeks prior to the screening visit.
boolean
ID.7
Item
patients who received any anti-diabetic drug other than su or metformin within 12 weeks prior to the screening visit.
boolean
ID.8
Item
diabetes other than type 2 diabetes (e.g. type 1 diabetes, diabetes secondary to pancreatic disorders, drug or chemical agent intake…)
boolean
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean